Back to GetFilings.com



Table of Contents

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

FORM 10-Q

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarter ended June 30, 2003

OR

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

COMMISSION FILE NUMBER 000-31687

 
EVERGREEN SOLAR, INC.
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
     
DELAWARE   04-3242254
(STATE OR OTHER JURISDICTION OF
INCORPORATION OR ORGANIZATION)
  (I.R.S. EMPLOYER
IDENTIFICATION NUMBER)
 
259 Cedar Hill Street
Marlboro, Massachusetts 01752
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)
 
(508) 357-2221
(REGISTRANT’S TELEPHONE NUMBER, INCLUDING AREA CODE)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes __X__      No ____

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).

Yes ____     No __X__

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: As of July 29, 2003 there were 11,411,646 shares of common stock outstanding.


 


EVERGREEN SOLAR, INC.
QUARTERLY REPORT ON FORM 10-Q
FOR THE QUARTER ENDED JUNE 30, 2003

TABLE OF CONTENTS

Condensed Consolidated Balance Sheets
Condensed Consolidated Statements of Operations
Condensed Consolidated Statements of Cash Flows
Notes to Condensed Consolidated Financial Statements
Item 2. Management’s Discussion
Item 3. Quantitative and Qualitative Disclosure about Market Risk
Item 4. Controls and Procedures
Item 2. Changes in Securities and Use Of Proceeds
Item 4. Submission of Matters to a Vote of Security Holders
Item 6. Exhibits and Reports on Form 8-K
EX-10.1 Indemnification Agreement-Tim Woodward
EX-10.2 Indemnification Agreement-Philip Deutch
EX-10.3 Indemnification Agreement-Charles McDermot
EX-10.4 Indemnification Agreement-Lue Charron
EX-31.1 Section 302 Certification-CEO
EX-31.2 Section 302 Certification-CFO
EX-32.1 Section 906 Certification-CEO
EX-32.2 Section 906 Certification-CFO


Table of Contents

TABLE OF CONTENTS

             
PART I — FINANCIAL INFORMATION
       
 
 
ITEM 1: FINANCIAL STATEMENTS
  Page
 
   
Unaudited Condensed Consolidated Balance Sheets at December 31, 2002 and June 30, 2003
    3  
 
   
Unaudited Condensed Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2002 and June 30, 2003
    4  
 
   
Unaudited Condensed Consolidated Statements of Cash Flows for the Three and Six Months Ended June 30, 2002 and June 30, 2003
    5  
 
   
Notes to Condensed Consolidated Financial Statements
    6  
 
 
ITEM 2: MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
    11  
 
 
ITEM 3: QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK
    25  
 
 
ITEM 4: CONTROLS AND PROCEDURES
    25  
 
PART II — OTHER INFORMATION
       
 
 
ITEM 2: CHANGES IN SECURITIES AND USE OF PROCEEDS
    26  
 
 
ITEM 4: SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
    27  
 
 
ITEM 6: EXHIBITS AND REPORTS ON FORM 8-K
    28  
 
SIGNATURES
       
 
EXHIBIT INDEX
       

2


Table of Contents

CONDENSED CONSOLIDATED BALANCE SHEETS

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

Evergreen Solar, Inc.
Condensed Consolidated Balance Sheets
(in thousands, except share data)
(unaudited)

                     
        June 30,   December 31,
        2003   2002
       
 
Assets
               
Current assets:
               
Cash and cash equivalents
  $ 12,058     $ 1,194  
 
Marketable securities
    17,138       7,289  
 
Accounts receivable, net of allowance for doubtful accounts of $230 and $140 at December 31, 2003 and June 30, 2002, respectively
    2,995       2,848  
 
Interest receivable
    178       57  
 
Inventory
    2,158       2,194  
 
Other current assets
    698       1,012  
 
   
     
 
   
Total current assets
    35,225       14,594  
Restricted cash
    414       464  
Fixed assets, net
    18,617       16,905  
 
   
     
 
Total assets
  $ 54,256     $ 31,963  
 
   
     
 
 
Liabilities, convertible preferred stock and stockholders’ equity
               
Current liabilities:
               
 
Accounts payable
  $ 881     $ 861  
 
Accrued employee compensation
    570       569  
 
Accrued warranty
    376       326  
 
Other accrued expenses
    216       294  
 
   
     
 
   
Total current liabilities
    2,043       2,050  
 
Convertible preferred stock
               
 
Series A, $.01 par value, 26,227,668 and none shares authorized, 26,227,668 and none issued and outstanding at June 30, 2003 and December 31, 2002, respectively
    29,742        
 
Stockholders’ equity:
               
Common stock, $0.01 par value, 70,000,000 and 30,000,000 shares authorized, 11,411,646 and 11,410,826 issued and outstanding at June 30, 2003
               
 
and December 31, 2002, respectively
    114       114  
Additional paid-in capital
    70,513       71,508  
Accumulated other comprehensive income (loss)
    (54 )     7  
Accumulated deficit
    (47,880 )     (41,356 )
Deferred compensation
    (222 )     (360 )
 
   
     
 
 
Total stockholders’ equity
    22,471       29,913  
 
   
     
 
Total liabilities, convertible preferred stock and stockholders’ equity
  $ 54,256     $ 31,963  
 
   
     
 

The accompanying notes are an integral part of these financial statements.

3


Table of Contents

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

Evergreen Solar, Inc.
Condensed Consolidated Statements of Operations
(in thousands, except per share data)
(unaudited)

                                     
        Three months ended   Six months ended
        June 30,   June 30,
       
 
        2003   2002   2003   2002
       
 
 
 
Revenues:
                               
 
Product revenues
  $ 2,659     $ 1,075     $ 3,727     $ 1,988  
 
Research revenues
    508       207       889       443  
 
   
     
     
     
 
Total revenues
    3,167       1,282       4,616       2,431  
Operating expenses:
                               
 
Cost of product revenues
    4,242       2,791       6,907       5,695  
 
Research and development expenses, including costs of research revenues
    1,072       989       1,786       1,842  
 
Selling, general and administrative expenses
    1,202       1,187       2,521       2,243  
 
   
     
     
     
 
Total operating expenses
    6,516       4,967       11,214       9,780  
 
   
     
     
     
 
Operating loss
    (3,349 )     (3,685 )     (6,598 )     (7,349 )
 
Interest income, net
    50       210       74       452  
 
   
     
     
     
 
Net loss
    (3,299 )     (3,475 )     (6,524 )     (6,897 )
 
Accretion of Series A convertible preferred stock
    (12,055 )           (12,055 )      
 
   
     
     
     
 
Net loss attributed to common stockholders
    (15,354 )     (3,475 )     (18,579 )     (6,897 )
 
Other comprehensive income:
                               
   
Unrealized gain (loss) on marketable securities
    (55 )     (62 )     (61 )     93  
 
   
     
     
     
 
Comprehensive loss
  $ (15,409 )   $ (3,537 )   $ (18,640 )   $ (6,804 )
 
   
     
     
     
 
Net loss per common share (basic and diluted)
  $ (1.35 )   $ (0.30 )   $ (1.63 )   $ (0.60 )
Weighted average shares used in computing basic and diluted net loss per common share
    11,412       11,404       11,411       11,401  

The accompanying notes are an integral part of these financial statements.

4


Table of Contents

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

Evergreen Solar, Inc.
Condensed Consolidated Statements of Cash Flows
(in thousands)
(unaudited)

                     
        Six Months Ended
        June 30,
       
        2003   2002
       
 
Cash flows from operating activities:
               
 
Net loss
  $ (6,524 )   $ (6,897 )
 
Adjustments to reconcile net loss to net cash used in operating activities:
               
 
Depreciation expense
    1,023       990  
 
Bad debt expense
    83       62  
 
Amortization of bond premiums
    50       164  
 
Write-off of fixed assets
          43  
 
Issuance of stock options to consultants
    37        
 
Compensation expense associated with employee stock options
    138       143  
 
 
Changes in operating assets and liabilities:
               
   
Inventory
    36       (1,027 )
   
Other current assets
    314       (14 )
   
Interest receivable
    (121 )     137  
   
Accounts receivable
    (230 )     (880 )
   
Accounts payable
    20       (174 )
   
Accrued expenses
    57       138  
 
   
     
 
Net cash used in operating activities
    (5,117 )     (7,315 )
 
Cash flows from investing activities:
               
 
Purchases of fixed assets
    (2,735 )     (665 )
 
Restricted cash
    50        
 
Purchases of marketable securities
    (17,211 )     (5,092 )
 
Proceeds from sale and maturity of marketable securities
    7,251       11,304  
 
   
     
 
Net cash provided by (used in) investing activites
    (12,645 )     5,547  
 
Cash flows from financing activities:
               
 
Financing costs on issuance of Series A convertible preferred stock
    (849 )      
 
Proceeds from the issuance of Series A convertible preferred stock
    29,375        
 
Proceeds from the issuance of common stock warrant
    100          
 
Proceeds from the exercise of stock options and warrants
          7  
 
   
     
 
Net cash flow provided by financing activities
    28,626       7  
 
   
     
 
Net increase (decrease) in cash and cash equivalents
    10,864       (1,761 )
Cash and cash equivalents at beginning of period
    1,194       2,554  
 
   
     
 
Cash and cash equivalents at end of period
  $ 12,058     $ 793  
 
   
     
 
 
Supplemental cash flow information:
               
 
Taxes paid
    13       14  
 
Non-cash Series A convertible preferred stock dividends earned
    367        

The accompanying notes are an integral part of these financial statements.

5


Table of Contents

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

     1.     Basis of Presentation

The accompanying condensed consolidated interim financial statements of Evergreen Solar, Inc. (“Evergreen Solar” or the “Company”) are unaudited and have been prepared on a basis substantially consistent with the Company’s audited financial statements for the year ended December 31, 2002. The condensed consolidated interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information. Consequently, these statements do not include all disclosures normally required by generally accepted accounting principles for annual financial statements. These condensed consolidated interim financial statements should be read in conjunction with the Company’s audited financial statements for the year ended December 31, 2002, which are contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2002, which was filed with the Securities and Exchange Commission on March 27, 2003. The unaudited condensed consolidated interim financial statements, in the opinion of management, reflect all adjustments (consisting only of normal recurring accruals) necessary for a fair presentation of the financial position at June 30, 2003, the results of operations for the three and six month periods ended June 30, 2003 and 2002, and the cash flows for the three and six month periods ended June 30, 2003 and 2002. The balance sheet at December 31, 2002 has been derived from audited financial statements as of that date. The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for any other interim period or for the full fiscal year ending December 31, 2003.

The Company has historically financed operations and met capital expenditures requirements primarily through sales of capital stock and, to a lesser extent, research and product revenues. The first of the Marlboro facility’s two manufacturing lines became operational in 2001. As more fully described in Note 8 “Stockholders Equity,” on May 15, 2003, the Company consummated the private placement transaction contemplated by the purchase agreement entered into on March 21, 2003 with certain investors to raise $29,475,000 through the issuance of 26,227,668 shares of Series A convertible preferred stock and the sale of a warrant to purchase 2,400,000 shares of common stock. The proceeds to the Company, net of financing expenses of approximately $849,000, were approximately $28.6 million. The Company expects to use the net proceeds from this transaction to fund the construction of the second manufacturing line and other operations of the Company. The Company expects portions of the second manufacturing line to become operational in late 2003 and that it will be completed in 2004. As of June 30, 2003, our outstanding commitments for capital expenditures were approximately $4.5 million. Nearly all of our commitments for capital expenditures are associated with infrastructure improvements and equipment purchases for our manufacturing facility. In addition to the current capital commitments, substantial further capital expenditures will be required over the next twelve to eighteen months to increase the capacity at our manufacturing facility to our target level of 10 to 14 megawatts for both lines.

The Company may need additional financing to execute its business plan if the Company needs to respond to business contingencies such as the need to enhance its operating infrastructure, respond to competitive pressures and acquire complementary businesses or necessary technologies. The Company does not know whether it will be able to raise additional financing on favorable financing terms. If adequate funds are not available or are not available on acceptable terms, the Company’s ability to fund its operations, develop and expand its manufacturing operations and distribution network, or otherwise respond to competitive pressures would be significantly limited.

2. Net Income (Loss) per Common Share

The Company computes net loss per common share in accordance with SFAS No. 128, “Earnings Per Share” (“SFAS 128”), and SEC Staff Accounting Bulletin No. 98 (“SAB 98”). Under the provisions of SFAS 128 and SAB 98, basic net loss per common share is computed by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. The calculation of diluted net loss per common share for the three and six month periods ended June 30, 2002 and 2003 does not include 1,549,589 and 30,520,239 potential shares of common stock equivalents outstanding at June 30, 2002 and 2003, respectively, as their inclusion would be antidilutive.

6


Table of Contents

3. Inventory

     A summary of inventories is as follows:

                 
    June 30,   December 31,
    2003   2002
   
 
Raw materials
  $ 1,143,000     $ 1,236,000  
Work-in-process
    89,000       148,000  
Finished goods
    926,000       810,000  
 
   
     
 
 
  $ 2,158,000     $ 2,194,000  
 
   
     
 

4. Guarantor Arrangements

In November 2002, the FASB issued FASB Interpretation No. 45 (“FIN 45”) “Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others an interpretation of FASB Statements No. 5, 57, and 107 and rescission of FASB Interpretation No. 34.” FIN 45 requires that a guarantor recognize, at the inception of a guarantee, a liability for the fair value of the obligation undertaken by issuing the guarantee. The accounting requirements for the initial recognition of guarantees are applicable on a prospective basis for guarantees issued or modified after December 31, 2002. The disclosure requirements are effective for all guarantees outstanding, regardless of when they were issued or modified, during the first quarter of fiscal 2003. The adoption of FIN 45 did not have a material effect on the Company’s consolidated financial statements. The following is a summary of the Company’s agreements that we have determined are within the scope of FIN 45.

Product warranty

The Company provides for the estimated cost of product warranties at the time revenue is recognized. Given the Company’s limited operating history, the Company uses historical industry solar panel failure rates as the basis for the accrued warranty costs during the period. While the Company engages in product quality programs and processes, including monitoring and evaluating the quality of component suppliers, its warranty obligation is affected by product failure rates and material usage and service delivery costs incurred in correcting a product failure. If the Company’s actual product failure rates, material usage or service delivery costs differ from these estimates, accrued warranty costs would be adjusted in the period that such events or costs become known. Since the Company has a limited operating history and its manufacturing process differs from industry standards, their experience may be different from the industry data used as a basis for its estimate. While the Company’s methodology takes into account these uncertainties, adjustments in future periods may be required as its products mature. The following table summarizes the activity regarding the Company’s warranty accrual during the first half of 2003:

         
Balance at December 31, 2002
  $ 326,000  
Accruals for warranties issued during the period
    50,000  
Settlements made during the period
     
 
   
 
Balance at the end of the period
  $ 376,000  
 
   
 

Indemnification agreements

The Company enters into standard indemnification agreements in its ordinary course of business. Pursuant to these agreements, the Company indemnifies, holds harmless, and agrees to reimburse the indemnified party for losses suffered or incurred by the indemnified party, generally our business partners, directors and officers. The term of these indemnification agreements is generally perpetual any time after execution of the agreement. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements under certain circumstances may be unlimited. However, the Company has never incurred costs to defend lawsuits or settle claims related to these indemnification agreements. Furthermore, the Company has a Director and Officer insurance policy pursuant to which the Company may recover all or a portion of amounts it pays to directors and officers under their indemnification agreements. As a result of the Company’s insurance policy coverage, the Company believes the estimated fair value of these indemnification agreements is minimal. The Company believes the estimated fair value of agreements with parties other than its directors and officers is minimal as well.

7


Table of Contents

The Company agreed to indemnify, defend and hold harmless each of the purchasers participating in the Company’s Series A private placement financing transaction, their affiliates and their respective officers, directors, agents, employees, subsidiaries, partners, members and controlling persons to the fullest extent permitted by law from and against any and all losses, claims or written threats thereof, damages, expenses (including reasonable fees, disbursements and other charges of counsel) resulting from or arising out of the Company’s breach of any representation or warranty, covenant or agreement in the purchase agreement. The Company believes the estimated fair value of this indemnification agreement is minimal.

5. Deferred Compensation and Equity Related Charges

Prior to December 31, 2000, the Company recorded total cumulative deferred compensation of approximately $1.3 million representing the difference between the fair market value of the Company’s common stock and the exercise price on the option grant date. These amounts were presented as a reduction of stockholders’ equity and are being amortized ratably over the vesting period of the options, which is generally four years. The amortization resulted in charges to operations of $143,000 and $138,000 for the six months ended June 30, 2002 and 2003, respectively.

6. Stock Based Compensation

The Company applies the accounting provisions of Accounting Principles Board (“APB”) Opinion 25 and related interpretations and has elected the disclosure-only alternative permitted under Statement of Financial Accounting Standards Board (“SFAS”) No. 123, “Accounting for Stock-Based Compensation.” The Company has disclosed herein pro forma net income (loss) in the footnotes using the fair value based method. All stock-based awards to non-employees are accounted for at their fair market value, as calculated using the Black-Scholes model in accordance with SFAS No. 123.

The Company applies APB Opinion No. 25 and related interpretations in accounting for its stock option plan. Had compensation expense for the employee stock option plan been determined based on the fair value at the grant dates for options granted under the plan consistent with the method of SFAS No. 123, net loss would have been as follows (in thousands, except per share data):

                                                                 
            Three Months Ended                   Six Months Ended        
   
 
    June 30, 2002   June 30, 2003   June 30, 2002   June 30, 2003
   
 
 
 
    Net Loss   Net Loss   Net Loss   Net Loss   Net Loss   Net Loss   Net Loss   Net Loss
    Attributable   Per   Attributable   Per   Attributable   Per   Attributable   Per
    To Common   Common   To Common   Common   To Common   Common   To Common   Common
    Stockholders   Share   Stockholders   Share   Stockholders   Share   Stockholders   Share
   
 
 
 
 
 
 
 
Net loss attributed to common stockholders, as reported
  $ (3,475 )   $ (0.30 )   $ (15,354 )   $ (1.35 )   $ (6,897 )   $ (0.60 )   $ (18,579 )   $ (1.63 )
Add: Stock-based employee compensation expense included in reported results
    72       0.01       69       0.01       143       0.01       138       0.01  
Deduct: Total stock-based employee compensation expense determined under the fair-value-based method for all awards
    (279 )     (0.02 )     (291 )     (0.03 )     (573 )     (0.05 )     (578 )     (0.05 )
 
   
     
     
     
     
     
     
     
 
Pro forma net loss attributed to common stockholders
  $ (3,682 )   $ (0.31 )   $ (15,576 )   $ (1.37 )   $ (7,327 )   $ (0.64 )   $ (19,019 )   $ (1.67 )
 
   
     
     
     
     
     
     
     
 

8


Table of Contents

7. Segment Information

The Company operates as one operating segment. The following table summarizes the Company’s concentration of total revenue:

                   
      Six Months Ended